At the news
? NEUTRALIMPACT 2/10 CLUSTER filed Sep 15, 2026 at 18:00 ET
Two insiders at Revolution Medicines sold shares in a cluster totaling ~$1.37M in open-market sales, with additional derivative exercises and same-day sales by the CFO and a director. The sales are modest relative to the $43.9B market cap (~0.003%), making them routine and non-informative. The CFO's sales coincide with option exercises, suggesting tax-related or liquidity-driven transactions rather than a bearish signal. The director's single small sale is immaterial. No buying activity is present, and the cluster lacks the materiality or conviction to warrant a directional read.
- Two insiders sold shares: CFO Stephen Michael Kelsey sold ~$18.7M in open-market sales (across multiple trades on Sep 11) and exercised options; Director Lorence H. Kim sold 706 shares for ~$146K on Sep 8.
- Total open-market sales in the cluster: ~$1.37M (Kelsey's sales are part of a larger 7-day pattern but the cluster window captures only a subset).
- Sales represent ~0.003% of RVMD's $43.9B market cap, well below the 0.1% threshold for materiality.
- CFO's sales coincide with option exercises at strike prices of $40.74 and $42.45, indicating a cashless exercise-and-sell pattern typical of tax withholding or liquidity needs.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access